Louisiana HR174 urges the state surgeon general and the Louisiana Department of Health to assess fenbendazole for potential human use in cancer.
Louisiana HR174 requests the state surgeon general and the Louisiana Department of Health to assess the feasibility of fenbendazole, a veterinary drug, for potential human use in cancer treatment. The bill also asks for guidance on engaging federal authorities for expedited evaluation while protecting public health. The resolution highlights the need for rigorous patient safety and evidence-based standards. The findings and recommendations are to be submitted to the House Committee on Health and Welfare by February 1, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.